All Research on Pharmaceutical Manufacturers in Europe

Insight

Case Studies
Case Studies

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

This case study looks at Teva's operations and the market in which it operates, Copaxone, Teva's best-selling drug, and M&A activity Teva has been involved in over recent years, and whether or not it has been successful.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Orphan Drugs: Rescue from the patent cliff

Big Pharma has gone through some significant changes in recent years: many “blockbuster” drugs are losing their patents. In the orphan drugs market, where companies can charge high premiums for drugs which have little to no competition.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Pfizer Inc: Re-entry to the OTC healthcare market

Pfizer exited the OTC healthcare market in 2006 with the sale of its Consumer Healthcare division. In 2009, Pfizer re-entered the market. This case study will examine Pfizer's growth, disposal of the OTC division, and the subsequent market re-entry.

Published By MarketLine
$495
Buy

View all Insight >>

Market Data

Databook
Databook

Company Financials: Shire plc

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
$75
Buy

Profiles

Company Profile
Company Profile

Krka, d. d., Novo mesto

Krka, d. d., Novo mesto (Krka or 'the group'), is a Slovenia-based provider of prescription pharmaceuticals, self-medication products, and animal health products. The group is also engaged in the health resort business and providing tourist services. The group primarily operates in Europe. It is headquartered in Novo Mesto, Slovenia and employed 10,048 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Boehringer Ingelheim GmbH

Boehringer Ingelheim (BI or 'the group') is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, and animal health products. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. BI employed 47,492 people in 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Sanofi SA

Sanofi (or 'the group') is a France-based international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers biopharmaceuticals, human vaccines and animal and consumer health products. The group operates in more than 100 countries. It is headquartered in Paris, France, and employed 112,128 people as of December 31, 2013.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.